Skip to main content
MedPathMedPath Home
Clinical Trials/ISRCTN39643421
ISRCTN39643421
Completed
Not Applicable

Trial of Short Course Therapy in Elderly Patients with High Grade Non-Hodgkin's Lymphoma

K Co-ordinating Committee for Cancer Research (UKCCCR)0 sites0 target enrollmentAugust 19, 2002
Share to TwitterShare to FacebookShare to LinkedInShare to Reddit
Conditionsymphoma (non-Hodgkin's)CancerLymphoma (non-Hodgkin's)

Overview

Phase
Not Applicable
Intervention
Not specified
Conditions
ymphoma (non-Hodgkin's)
Sponsor
K Co-ordinating Committee for Cancer Research (UKCCCR)
Status
Completed
Last Updated
11 years ago
OverviewInvestigatorsEligibility CriteriaOutcomesSimilar Trials

Overview

Brief Summary

No summary available.

Registry
who.int
Start Date
August 19, 2002
End Date
TBD
Last Updated
11 years ago
Study Type
Interventional

Investigators

Sponsor
K Co-ordinating Committee for Cancer Research (UKCCCR)

Eligibility Criteria

Inclusion Criteria

  • •1\. Aged 60 to 85 years
  • •2\. Newly presenting high grade lymphoma presenting as:
  • •2\.1 Follicular lymphoma
  • •2\.2 Diffuse large cell lymphoma including immunoblastic
  • •2\.3 Diffuse mixed cell lymphoma \- Lymphoblastic and Burkitt's lymphoma are excluded
  • •3\. Stage IB\-IV
  • •4\. Patients must be free from any other irreversible medical condition that would drastically limit their lifespan or prohibit the use of combination chemotherapy

Exclusion Criteria

  • •Not provided at time of registration

Outcomes

Primary Outcomes

Not specified

Similar Trials

Not yet recruiting
Not Applicable
Prospective study of treatment for elderly patients with PAD (peripheral arterial disease) using Propensity Score Analysisperipheral arterial disease
JPRN-UMIN000013630Hakodate cardiovascular disease round-table conference2,000
Active, not recruiting
Phase 1
Randomized phase III trial in elderly patients with previously untreated symptomatic Multiple Myeloma comparing MP-Thalidomide (MP-Thal) followed by Thalidomide maintenance versus MP-Lenalidomide (MP-Len) follwed by maintenance with Lenalidomide.
EUCTR2007-004007-34-SEHOVON Foundation668
Completed
Phase 3
Randomized phase III trial in elderly patients with previously untreated symptomatic Multiple Myeloma comparing MP-Thalidomide (MP-Thal) followed by thalidomide maintenance versus MP-Lenalidomide (MP-Len) followed by maintenance with lenalidomideKahlers diseaseMultiple Myeloma10035227
NL-OMON50624HOVO500
Active, not recruiting
Phase 1
Randomized phase III trial in elderly patients with previously untreated symptomatic Multiple Myeloma comparing MP-Thalidomide (MP-Thal) followed by thalidomide maintenance versus MP-Lenalidomide (MP-Len) followed by maintenance with lenalidomide - HOVON 87 MMMultiple MyelomaMedDRA version: 14.1Level: PTClassification code 10028228Term: Multiple myelomaSystem Organ Class: 10029104 - Neoplasms benign, malignant and unspecified (incl cysts and polyps)
EUCTR2007-004007-34-DKHOVON Foundation668
Active, not recruiting
Phase 1
Randomized phase III trial in elderly patients with previously untreated symptomatic Multiple Myeloma comparing MP-Thalidomide (MP-Thal) followed by thalidomide maintenance versus MP-Lenalidomide (MP-Len) followed by maintenance with lenalidomideMultiple MyelomaMedDRA version: 21.0 Level: LLT Classification code 10028228 Term: Multiple myeloma System Organ Class: 100000004864Therapeutic area: Diseases [C] - Cancer [C04]
EUCTR2007-004007-34-NLHOVON Foundation668